The landscape of dementia analysis has advanced drastically with the appearance of advanced biomarkers, together with amyloid PET scans, tau imaging, and blood-primarily based assessments which can detect Alzheimer's pathology a long time in advance of symptoms emerge. Even though these technological advancements represent exceptional development i